Infanrix IPV (difterie-anatoxine + tetanus-anatoxine + Bordetella pertussis antigenen + poliomyelitisvirus types I, II, III geïnactiveerd suspensie voor injectie (i.m.) (zuigel. en kind)) · CNK 1552215

Product information

Infanrix IPV
1 dose (0.5 ml)
difterie-anatoxine + tetanus-anatoxine + Bordetella pertussis antigenen + poliomyelitisvirus types I, II, III geïnactiveerd suspensie voor injectie (i.m.) (zuigel. en kind)
1552215
8.03 / 10
Locked

Product properties

x
J07CA02
GlaxoSmithKline Biologicals
Suspension for injection
BE212152
05050459001443, 05050459002815, 05050459006721, 05400571000808
M1
Public
212152-01

Pharmacist Assessment

Normally available

This product has good current availability (score 8.03/10) and is historically stable (score 🔒/10). No action required.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 16 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Available Active
Published 30/06/2023

Composition

9 ingredients

Substance Type Strength CAS
Active ingredient
25 ug/{dose}
Active ingredient
25 ug/{dose}
Active ingredient
40 [iU]/{dose}
Active ingredient
40 [D'ag'U]
Active ingredient
32 [D'ag'U]
Active ingredient
8 [D'ag'U]
Active ingredient
8 ug/{dose}
Active ingredient
30 [iU]/{dose}
Excipient
4.5 mg/{dose}

Additional information

Availability statistics

Available
0 days
2
0